Cancer Diagnosis, Then a Stroke; 9/11 Cancer Deaths; ‘Grand Slam’ Drug and Price

Patients with cancer had an increased risk of ischemic stroke, particularly in the first few months after diagnosis, most notably in patients with lung and pancreatic cancer, according to a large retrospective cohort study. (Cancer)

The FDA expanded the label for the tyrosine kinase inhibitor sevabertinib (Hyrnuo) to include first-line therapy for locally advanced/metastatic nonsquamous non-small cell lung cancers (NSCLCs) harboring HER2 tyrosine kinase domain activating mutations.

On the 25th anniversary of the 9/11 terrorist attack, the number of cancer deaths linked to the incident has surpassed the number of people who died that day. (News 12)

A 30-year-old Australian woman has turned her years-long struggle with symptoms of undiagnosed colon cancer into a book about the experience. (People)

Actor Bruce Campbell, 68, known for the “Evil Dead” movie franchise and the cable TV series “Burn Notice,” acknowledged he has a life expectancy of 5 years, “give or take,” because of his undisclosed type of cancer. (USA Today)

“Well, that was her business.” Dolly Parton’s sister, Stella, explains why the late entertainer never disclosed the type of cancer she had. (The Independent)

People with disabilities have significantly lower rates of screening for breast, cervical, and colorectal cancer, meaning that potentially millions of Americans are missing out on the benefits of early detection. (American Cancer Society)

Moderna announced plans to raise $2.6 billion to support its further development of therapeutic cancer vaccines.

The pancreatic cancer drug daraxonrasib (Rasonque) not only set a new standard of care but also a new standard of cost for oncology drugs. (New York Times)

With the closure of the daraxonrasib expanded access program, some patients who might benefit from the treatment are struggling to get access. (STAT)

People more likely to consume very hot drinks had a threefold higher risk of esophageal squamous cell carcinoma in an analysis of 1 million U.K. adults. (International Journal of Cancer)

Locally advanced head and neck cancer that responds to neoadjuvant immunochemotherapy may allow patients to have less extensive surgery. (American Association for Cancer Research)

Adding atezolizumab (Tecentriq) induction and consolidation to stereotactic body radiation therapy failed to improve overall survival in a phase III trial of inoperable early-stage NSCLC versus radiation alone. (The Lancet)

Medicare Advantage plans appear poised to make substantial cuts in benefits in 2027. (Axios)